EffectS of non-nutritive sWeetened beverages on appetITe during aCtive weigHt loss (SWITCH): Protocol for a randomized, controlled trial assessing the effects of non-nutritive sweetened beverages compared to water during a 12-week weight loss period and a follow up weight maintenance period

• Published in: Contemporary clinical trials Vol. 53; pp. 80 - 88
• Main Authors: Masic, U., Harrold, J.A., Christiansen, P., Cuthbertson, D.J., Hardman, C.A., Robinson, E., Halford, J.C.G.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-02-2017
• Subjects: Absorptiometry, Photon; Adult; Aged; Beverages; Body Composition; Body weight; Drinking Water; Female; Humans; Longitudinal Studies; Low calorie sweeteners (LCS); Male; Middle Aged; Non-nutritive sweeteners (NNS); Non-Nutritive Sweeteners - therapeutic use; Obesity; Obesity - therapy; Sugar-sweetened beverages (SSB); Weight loss; Weight Reduction Programs; Young Adult; Non-nutritive sweeteners (NNS); Sugar-sweetened beverages (SSB); Obesity; Low calorie sweeteners (LCS); Body weight; Weight loss
• ISSN: 1551-7144; 1559-2030
• DOI: 10.1016/j.cct.2016.12.012

Acute and medium-term intervention studies suggest that non-nutritive sweeteners (NNS) are beneficial for weight loss, however there is limited human data on the long-term effects of consuming NNS on weight loss, maintenance, and appetite. Further research is therefore required to elucidate the prolonged impact of NNS consumption on these outcome measures.
A randomized parallel groups design will be used to assess whether regular NNS beverage intake is equivalent to a water control in promoting weight loss over 12-weeks (weekly weight loss sessions; Phase I), then supporting weight maintenance over 40-weeks (monthly sessions; Phase II) and subsequently independent weight maintenance over 52-weeks (Phase III) in 432 participants. A subset of these participants (n=116) will complete laboratory-based appetite probe days (15 sessions; 3 sessions each at baseline, at the start of phase I and the end of each phase). A separate subset (n=50) will complete body composition scans (DXA) at baseline and at the end of each phase. All participants will regularly be weighed and will complete questionnaires and cognitive tasks to assess changes in body weight and appetitive behaviours. Measures of physical activity and biochemical markers will also be taken.
The trial will assess the efficacy of NNS beverages compared to water during a behavioural weight loss and maintenance programme. We aim to understand whether the impact of NNS on weight, dietary adherence and well-being are beneficial or transient and effects on prolonged successful weight loss and weight maintenance through sustained changes in appetite and eating behaviour.
Trial registration: Clinical Trials: NCT02591134; registered: 23.10.2015